BTSG vs. ESLA
BTSG (BrightSpring Health Services, Inc) and ESLA (Estrella Immunopharma Inc.) are both stocks. Both are in the Healthcare sector — BTSG in Health Information Services, ESLA in Biotechnology. Over the past year, BTSG returned 204.02% vs -16.52% for ESLA. Their 0.08 correlation means their historical movements had little consistent relationship.
Performance
BTSG vs. ESLA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BTSG achieves a 59.44% return, which is significantly higher than ESLA's -54.25% return.
BTSG
- 1D
- -18.07%
- 1M
- -13.50%
- 6M
- 52.05%
- YTD
- 59.44%
- 1Y
- 204.02%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 89.48%
ESLA
- 1D
- -0.89%
- 1M
- -27.36%
- 6M
- -36.28%
- YTD
- -54.25%
- 1Y
- -16.52%
- 3Y*
- -60.00%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -41.63%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $220.39M | $311.69M | $243.26M | |
| $22.97K | $34.41K | $39.55K |
BTSG vs. ESLA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
BTSG BrightSpring Health Services, Inc | 59.44% | 119.91% | 41.92% |
ESLA Estrella Immunopharma Inc. | -54.25% | 30.00% | -0.83% |
Correlation
The correlation between BTSG and ESLA is 0.06, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.06 |
Correlation (All Time) Calculated using the full available price history since Jan 26, 2024 | 0.08 |
Fundamentals
BTSG:
$11.72B
ESLA:
$30.71M
BTSG:
$1.67
ESLA:
-$0.34
BTSG:
$14.37B
ESLA:
$0.00
BTSG:
$1.78B
ESLA:
$0.00
BTSG:
$525.76M
ESLA:
-$13.25M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BTSG vs. ESLA — Risk / Return Rank
BTSG
ESLA
BTSG vs. ESLA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BrightSpring Health Services, Inc (BTSG) and Estrella Immunopharma Inc. (ESLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BTSG | ESLA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.49 | ||
| Sortino ratioReturn per unit of downside risk | +3.21 | ||
| Omega ratioGain probability vs. loss probability | 1.60 | 1.08 | +0.52 |
| Calmar ratioReturn relative to maximum drawdown | 10.52 | -0.20 | +10.71 |
| Martin ratioReturn relative to average drawdown | 59.98 | -0.30 | +60.28 |
Loading charts...
Drawdowns
BTSG vs. ESLA - Drawdown Comparison
The maximum BTSG drawdown since its inception was -35.56%, smaller than the maximum ESLA drawdown of -96.64%. Use the drawdown chart below to compare losses from any high point for BTSG and ESLA.
Loading charts...
Drawdown Indicators
| BTSG | ESLA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.56% | -96.64% | +61.08% |
Max Drawdown (1Y)Largest decline over 1 year | -18.10% | -76.60% | +58.50% |
Max Drawdown (3Y)Largest decline over 3 years | — | -96.64% | — |
Current DrawdownCurrent decline from peak | -18.10% | -96.64% | +78.54% |
Average DrawdownAverage peak-to-trough decline | -7.46% | -56.67% | +49.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.22% | 49.82% | -46.60% |
Volatility
BTSG vs. ESLA - Volatility Comparison
BrightSpring Health Services, Inc (BTSG) and Estrella Immunopharma Inc. (ESLA) have volatilities of 23.06% and 23.99%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BTSG | ESLA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.06% | 23.99% | -0.93% |
Volatility (6M)Calculated over the trailing 6-month period | 36.11% | 67.89% | -31.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.83% | 112.41% | -68.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.18% | 133.39% | -88.21% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.18% | 133.39% | -88.21% |
Dividends
BTSG vs. ESLA - Dividend Comparison
Neither BTSG nor ESLA has paid dividends to shareholders.
Financials
BTSG vs. ESLA - Financials Comparison
This section allows you to compare key financial metrics between BrightSpring Health Services, Inc and Estrella Immunopharma Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
BTSG and ESLA have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ESLA has higher volatility (23.99%) compared to BTSG (23.06%). In terms of maximum drawdown, BTSG dropped -35.56% vs ESLA's -96.64%.
BTSG currently has the higher Sharpe Ratio (4.36 vs -0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BTSG and ESLA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer